January 2011

DMF for Latanoprost API was filed with Slovenia and Croatia Regulatory Authorities.

November 2010

DMF for Latanoprost API was filed with German and French Regulatory Authorities.

July 2010

DMF for Nabilone API was filed with Health Canada.

June 15, 2010

The Company celebrated the 20th anniversary since its establishment.

May 2010

GMP certificate was renewed following a successful 4 day inspection of the Company’s facility and operations by the Israeli Ministry of Health.

April 2010

As part of a corporate restructuring, the Company was separated from RxElite and Dr. Arie L. Gutman became Chairman of the Board.